Therapeutic Drug Monitoring: Newer Drugs and Biomarkers
Editat de Amitava Dasguptaen Limba Engleză Hardback – 27 aug 2012
- Includes both the technical and clinical issues associated with therapeutic drug monitoring
- Discusses the utility of therapeutic drug monitoring of newer drugs such as antiretroviral agents, anticonvulsants, antidepressants etc.
- Provides up-to-date information on issues in pharmacogenomics and personalized medicine with emphasis on therapy with warfarin, certain anticancer drugs and antidepressants
- Covers important content on the limitations of commercially available immunoassays (chemical tests) for therapeutic drug monitoring and additional analytical techniques
Toate formatele și edițiile | Preț | Express |
---|---|---|
Hardback (2) | 765.32 lei 5-7 săpt. | |
ELSEVIER SCIENCE – 27 aug 2012 | 765.32 lei 5-7 săpt. | |
ELSEVIER SCIENCE – 25 apr 2024 | 947.42 lei 5-7 săpt. |
Preț: 765.32 lei
Preț vechi: 971.71 lei
-21% Nou
Puncte Express: 1148
Preț estimativ în valută:
146.48€ • 155.52$ • 121.33£
146.48€ • 155.52$ • 121.33£
Carte tipărită la comandă
Livrare economică 18 decembrie 24 - 01 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780123854674
ISBN-10: 0123854679
Pagini: 468
Ilustrații: 50 illustrations
Dimensiuni: 191 x 235 x 28 mm
Greutate: 1.13 kg
Ediția:New.
Editura: ELSEVIER SCIENCE
ISBN-10: 0123854679
Pagini: 468
Ilustrații: 50 illustrations
Dimensiuni: 191 x 235 x 28 mm
Greutate: 1.13 kg
Ediția:New.
Editura: ELSEVIER SCIENCE
Public țintă
The primary audience for this book includes toxicologists, pharmacologists, clinical pathologists, laboratory professionals and clinical chemists.Cuprins
Chapter 1. Introduction to Therapeutic Drug Monitoring: Frequently and Less Frequently Monitored Drugs
Chapter 2. Effects of Pre-Analytical Variables in Therapeutic Drug Monitoring
Chapter 3. Analytical Techniques used in Therapeutic Drug Monitoring
Chapter 4. Clinical Utility of Free Drug Monitoring
Chapter 5. Current Practice of Therapeutic Drug Monitoring: Dose Adjustment of Drugs using Pharmacokinetic models
Chapter 6. An Introduction to Personalized Medicine
Chapter 7. Application of Ultra-High Throughput Sequencing and Microarray Technologies in Pharmacogenomics Testing
Chapter 8. Pharmacogenomics and Warfarin therapy
Chapter 9. Applications of Pharmacokinetic and Pharmacodynamic Principles to Optimize Drug Dosage Selection: Example of Antibiotic Therapy Management
Chapter 10. Guidelines for Monitoring of Vancomycin, Aminoglycosides and certain antibiotics .
Chapter 11. Challenges in Therapeutic Drug Monitoring of Digoxin and other Antiarrhythmic Drugs
Chapter 12. Therapeutic Drug Monitoring of Classical and Newer Anticonvulsants
Chapter 13. Challenges in Therapeutic Drug Monitoring of Classical Tricyclic and Newer Antidepressants: Analytical and Pharmacogenetics Considerations
Chapter14. Therapeutic Drug Monitoring of Selected Anticancer Drugs: Pharmacogenomics issues
Chapter 15. Immunosuppressive Drug Monitoring: Limitations of Immunoassays and the Application of Liquid Chromatography Mass Spectrometry
Chapter 16. Biomarkers: The Link between Therapeutic Drug Monitoring and Pharmacodynamics of Immunosuppressants
Chapter 17. Therapeutic Drug Monitoring of Antiretroviral Drugs in the Management of Human Immunodeficiency Infection
Chapter 18. Drug Testing in Pain Management
Chapter 19. Role of Therapeutic Drug Monitoring to Identify Clinically Significant Drug-Herbal Supplement Interaction
Chapter 2. Effects of Pre-Analytical Variables in Therapeutic Drug Monitoring
Chapter 3. Analytical Techniques used in Therapeutic Drug Monitoring
Chapter 4. Clinical Utility of Free Drug Monitoring
Chapter 5. Current Practice of Therapeutic Drug Monitoring: Dose Adjustment of Drugs using Pharmacokinetic models
Chapter 6. An Introduction to Personalized Medicine
Chapter 7. Application of Ultra-High Throughput Sequencing and Microarray Technologies in Pharmacogenomics Testing
Chapter 8. Pharmacogenomics and Warfarin therapy
Chapter 9. Applications of Pharmacokinetic and Pharmacodynamic Principles to Optimize Drug Dosage Selection: Example of Antibiotic Therapy Management
Chapter 10. Guidelines for Monitoring of Vancomycin, Aminoglycosides and certain antibiotics .
Chapter 11. Challenges in Therapeutic Drug Monitoring of Digoxin and other Antiarrhythmic Drugs
Chapter 12. Therapeutic Drug Monitoring of Classical and Newer Anticonvulsants
Chapter 13. Challenges in Therapeutic Drug Monitoring of Classical Tricyclic and Newer Antidepressants: Analytical and Pharmacogenetics Considerations
Chapter14. Therapeutic Drug Monitoring of Selected Anticancer Drugs: Pharmacogenomics issues
Chapter 15. Immunosuppressive Drug Monitoring: Limitations of Immunoassays and the Application of Liquid Chromatography Mass Spectrometry
Chapter 16. Biomarkers: The Link between Therapeutic Drug Monitoring and Pharmacodynamics of Immunosuppressants
Chapter 17. Therapeutic Drug Monitoring of Antiretroviral Drugs in the Management of Human Immunodeficiency Infection
Chapter 18. Drug Testing in Pain Management
Chapter 19. Role of Therapeutic Drug Monitoring to Identify Clinically Significant Drug-Herbal Supplement Interaction